Curran Daniel J.

Director at ALX ONCOLOGY HOLDINGS INC · on record since Aug 13, 2025
Director at CATALYST PHARMACEUTICALS, INC. · on record since Aug 8, 2025
Director at Xilio Therapeutics, Inc. · on record since Jun 12, 2026

Insider trading activity of Curran Daniel J.

Transactions on record: 10; since Jun 17, 2024

Open-market buys: 0

Open-market sells: 0

Companies traded: 3; last filing Jul 17, 2026

Figures computed from official regulatory filings — .

Companies where Curran Daniel J. has traded

CATALYST PHARMACEUTICALS, INC.5 tx · Jul 17, 2026
Xilio Therapeutics, Inc.3 tx · Jun 12, 2026
ALX ONCOLOGY HOLDINGS INC2 tx · Jan 21, 2026

Track record of Curran Daniel J.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Curran Daniel J.

Co-insiders of Curran Daniel J.

Alexandria Venture Investments, LLCXilio Therapeutics, Inc.
Andrews William T.CATALYST PHARMACEUTICALS, INC.
Atlas Venture Associates Opportunity I, LLCXilio Therapeutics, Inc.
Atlas Venture Associates Opportunity I, L.P.Xilio Therapeutics, Inc.
Atlas Venture Associates XI, LLCXilio Therapeutics, Inc.
Atlas Venture Associates XI, L.P.Xilio Therapeutics, Inc.
Atlas Venture Fund XI, L.P.Xilio Therapeutics, Inc.
Atlas Venture Opportunity Fund I, L.P.Xilio Therapeutics, Inc.
Bain Capital Life Sciences Fund II, L.P.Xilio Therapeutics, Inc.
Bain Capital Life Sciences Investors II, LLCXilio Therapeutics, Inc.
Bain Capital Life Sciences Investors, LLCXilio Therapeutics, Inc.
BAY CITY CAPITAL LLCXilio Therapeutics, Inc.
BCIP Life Sciences Associates, LPXilio Therapeutics, Inc.
BCLS II Investco, LPXilio Therapeutics, Inc.
BCLS II Investo (GP), LLCXilio Therapeutics, Inc.
Bello Akintunde OlatokumboXilio Therapeutics, Inc.
BIOMARIN PHARMACEUTICAL INCCATALYST PHARMACEUTICALS, INC.
Blanchard Cheryl RXilio Therapeutics, Inc.
Bonstein SaraXilio Therapeutics, Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Value · USD	Src
CATALYST PHARMACEUTICALS, INC.Security delisted	Jul 17, 2026	OtherD (derivative)	-40,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CATALYST PHARMACEUTICALS, INC.Security delisted	Jul 17, 2026	OtherD (derivative)	-5,468	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CATALYST PHARMACEUTICALS, INC.Security delisted	Jul 17, 2026	OtherD (derivative)	-18,115	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Xilio Therapeutics, Inc.Listing on record	Jun 12, 2026	AwardD (derivative)	5,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ALX ONCOLOGY HOLDINGS INCListing on record	Jan 21, 2026	AwardD (derivative)	16,833	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CATALYST PHARMACEUTICALS, INC.Security delisted	Nov 24, 2025	AwardD (derivative)	18,115	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CATALYST PHARMACEUTICALS, INC.Security delisted	Nov 24, 2025	AwardD (derivative)	5,468	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ALX ONCOLOGY HOLDINGS INCListing on record	Aug 13, 2025	AwardD (derivative)	40,400	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Xilio Therapeutics, Inc.Listing on record	Jun 12, 2025	AwardD (derivative)	31,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Xilio Therapeutics, Inc.Listing on record	Jun 17, 2024	AwardD (derivative)	25,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Value · USD	Src
CATALYST PHARMACEUTICALS, INC.Security delisted	Jul 17, 2026	OtherD (derivative)	-40,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CATALYST PHARMACEUTICALS, INC.Security delisted	Jul 17, 2026	OtherD (derivative)	-5,468	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CATALYST PHARMACEUTICALS, INC.Security delisted	Jul 17, 2026	OtherD (derivative)	-18,115	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Xilio Therapeutics, Inc.Listing on record	Jun 12, 2026	AwardD (derivative)	5,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ALX ONCOLOGY HOLDINGS INCListing on record	Jan 21, 2026	AwardD (derivative)	16,833	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CATALYST PHARMACEUTICALS, INC.Security delisted	Nov 24, 2025	AwardD (derivative)	18,115	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CATALYST PHARMACEUTICALS, INC.Security delisted	Nov 24, 2025	AwardD (derivative)	5,468	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ALX ONCOLOGY HOLDINGS INCListing on record	Aug 13, 2025	AwardD (derivative)	40,400	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Xilio Therapeutics, Inc.Listing on record	Jun 12, 2025	AwardD (derivative)	31,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Xilio Therapeutics, Inc.Listing on record	Jun 17, 2024	AwardD (derivative)	25,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC